1/2 REPRIEVE Extension for Trial Completion — Pamela Susan Douglas (MASSACHUSETTS GENERAL HOSPITAL)
Project Summary-Abstract Globally, cardiovascular disease (CVD) burden is increasing and a major cause of mortality among people with HIV (PWH). However, data are not yet available from large trials o
| Project title | 1/2 REPRIEVE Extension for Trial Completion |
|---|---|
| Project number | 4UG3HL164285-02 |
| PI name | Pamela Susan Douglas |
| Institution | MASSACHUSETTS GENERAL HOSPITAL |
| Funding mechanism | UG3 |
| Agency | NHLBI |
| Award amount | $4.75M |
| Fiscal year | 2024 |
| Project start | 2023-05-01T00:00:00 |
| Project end | 2026-04-30T00:00:00 |
| Abstract | Project Summary-Abstract Globally, cardiovascular disease (CVD) burden is increasing and a major cause of mortality among people with HIV (PWH). However, data are not yet available from large trials o |
| Key terms | <7S Gamma Globulin><AIDS><AIDS Virus><Acquired Immune Deficiency><Acquired Immune Deficiency Syndrom |
$799/mo
Try GrantRadar →